Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glaucoma in China: how big is the problem?

P J Foster1, G J Johnson

  • 1Department of Epidemiology and International Eye Health, Institute of Ophthalmology, University College London, London EC1V 9EL, UK. p.foster@ucl.ac.uk

The British Journal of Ophthalmology
|October 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model.

Diagnostic and interventional imaging·2020
Same author

A pragmatic randomized trial comparing tablet computer informed consent to traditional paper-based methods for an osteoporosis study.

Contemporary clinical trials communications·2018
Same author

Automated arteriole and venule classification using deep learning for retinal images from the UK Biobank cohort.

Computers in biology and medicine·2017
Same author

Experience of propofol sedation in a UK ERCP practice: lessons for service provision.

Frontline gastroenterology·2017
Same author

Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017

An estimated 9.4 million adults in China have glaucoma, with primary angle closure glaucoma (PACG) causing most bilateral blindness. Prevention strategies for PACG are crucial for reducing visual morbidity.

Area of Science:

  • Ophthalmology
  • Public Health
  • Epidemiology

Background:

  • Glaucoma is a leading cause of irreversible blindness worldwide.
  • Estimating the prevalence and burden of glaucoma in China is essential for public health planning.

Purpose of the Study:

  • To estimate the number of adults in China with glaucoma.
  • To project the visual morbidity associated with primary and secondary glaucoma.

Main Methods:

  • Utilized age and sex-specific data from population surveys.
  • Applied data to US Census Bureau population estimates for urban and rural China.
  • Assumed Singaporean data represented urban China and Mongolian data represented rural China.

Main Results:

Related Experiment Videos

  • Estimated 9.4 million Chinese adults (≥40 years) have glaucomatous optic neuropathy.
  • 5.2 million (55%) experience blindness in at least one eye; 1.7 million (18.1%) are bilaterally blind.
  • Primary angle closure glaucoma (PACG) accounts for 91% of bilateral glaucoma blindness; 28.2 million have predisposing traits for PACG.

    • Conclusions:

    • Glaucoma's visual morbidity in China is considerable.
    • PACG is likely the primary cause of bilateral glaucoma blindness.
    • Further investigation into PACG prevention strategies is warranted.